Alain C Borczuk

5PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGreenhouse gas inventories and fluxes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 03, 2024
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.

Nasser K Altorki, Zachary H Walsh, Johannes C Melms

|Dec 19, 2023
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.

Nasser K Altorki, Zachary H Walsh, Johannes C Melms

|Mar 25, 2022
Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression.

Seungyeul Yoo, Abhilasha Sinha, Dawei Yang

|Oct 07, 2021
Updates in grading and invasion assessment in lung adenocarcinoma.

Alain C Borczuk

|Mar 13, 2021
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions.

Daniel Butler, Christopher Mozsary, Cem Meydan

Pageof 1

Frequent Collaborators

3 joint publications

Nasser K Altorki

2 joint publications

Olivier Elemento

2 joint publications

Silvia C Formenti

2 joint publications

Amit Dipak Amin